Ticker: KALV

Company: Carbylan Therapeutics, Inc.

Person: Paul K Audhya, officer

Transaction date: Nov. 21, 2025

Reporting date: Nov. 26, 2025

Average share price: -11.96447699025865

Sold 5954.0 shares for 71236.5